AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Passive strategies for retirement prioritize low costs and broad market exposure, delivering reliable long-term growth without constant tweaking.
23,939 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Crypto venture funds are widening bets beyond coins, aiming at fintech, AI, and infrastructure. The shift is designed...
May data show 7.6 million job openings, topping forecasts and signaling stabilization in the labor market. Thursday's...
A federal judge granted Alibaba a temporary reprieve from the Defense Department lobbying ban as she weighs the compa...
A top Wall Street firm is offering interns as much as $8,600 per week for a 10-week program, a level that dwarfs typi...
BWET, the Breakwave Tanker Shipping ETF, has surged more than 1,000% year-to-date, defying AI-focused bets. The move...
SpaceX is attracting renewed investor interest as revenue streams expand beyond launches. With Starlink, NASA deals, ...
A late-July meeting to craft an ethics clause for the President’s crypto holdings stalled, keeping Clarity Act negoti...
RE/MAX reports a rise in 2025 net income to $8.2 million, driven by growth outside the U.S. even as U.S. agent counts...
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
Reddit still furious about AT&T's $47 billion write-down lingers as a new buyer group targets the legacy assets for r...
Kroger reports fiscal 2025 results with a GAAP payout surge caused by a major impairment, yet cash flow and 2026 earn...